BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  agreement: 10476     

HTML
100%
First Bauxite Enters Into Letter of Intent With Bauxite Corporation of Guyana Inc. to Acquire All of the Share
FIRST BAUXITE CORPORATION ('First Bauxite' or the 'Company') (TSX VENTURE: FBX)(FRANKFURT: FBI)(BERLIN: FBI) is pleased to announce that on February 5th, entered into a Letter of Intent with Bauxite Corporation of Guyana Inc.

('BCGI') to acquire all of the...

Genetic Engineering News:  Feb 10 2010 5:19AM
Matching: agreement
Find similar documents
HTML
100%
Abbot Sues Qiagen Over Pact for PCR-Based HPV Detection Methods
Abbott Laboratories last week sued Qiagen in a US court in a dispute over a licensing agreement related to patents covering PCR-based detection of human papillomavirus genotypes.

The suit, filed on Feb.

3 in the US District Court for the Northern...

GenomeWeb:  Feb 10 2010 3:04AM
Matching: agreement
Find similar documents
HTML
100%
California Court of Appeal Orders Arbitration, Finding Arbitration Agreement Not Unconscionable
An arbitration agreement permitting limited discovery and additional discovery upon a showing of need was not unconscionable, the California Court of Appeal has held, reversing a lower court order denying arbitration.

Dotson v.

Amgen, Inc., No.

Jackson Lewis:  Feb 9 2010 10:22PM
Matching: agreement
Find similar documents
HTML
100%
Delcath Signs First Partner Agreement in Asia
NEW YORK, Feb.

9 /PRNewswire-FirstCall/ -- Delcath Systems, Inc.

(Nasdaq: DCTH), a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today the signing of its first research,...

SmartBrief:  Feb 9 2010 6:25PM
Matching: agreement
Find similar documents
HTML
100%
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated
Caleco Pharma Corp.

(OTCBB: CAEH)(FRANKFURT: T3R)(WKN: A0N9Y0) ('Caleco Pharma') (www.calecopharmacorp.com) is pleased to announce that it has entered into a designated sponsorship agreement (the 'Sponsorship Agreement') with ICF Kursmakler AG (...

Market Wire via MSN Money:  Feb 9 2010 2:31PM
Matching: agreement
Find similar documents
HTML
100%
Westaim and NUCRYST Pharmaceuticals collaborate to form a new company
The Westaim Corporation (Westaim or the Company) (TSX: "WED") announced today that, following the approval of the transaction by the shareholders of NUCRYST Pharmaceuticals Corp.

(Nucryst), Westaim's wholly-owned subsidiary, 1499642 Alberta Ltd.

(1499642),...

News-Medical.Net:  Feb 9 2010 4:55AM
Matching: agreement
Find similar documents
HTML
100%
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater Advisory Group LLC
BELLINGHAM, WASHINGTON -- (Marketwire) -- 02/09/10 -- Caleco Pharma Corp.

(OTCBB: CAEH)(FRANKFURT: T3R)(WKN: A0N9Y0) ("Caleco Pharma") (www.calecopharmacorp.com) is pleased to announce that it has entered into a designated sponsorship agreement (the ...

EuroInvestor.co.uk:  Feb 9 2010 6:53PM
Matching: agreement
Find similar documents
HTML
100%
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater Advisory Group LLC as Investor Relations
BELLINGHAM, WASHINGTON--(Marketwire - Feb.

9, 2010) - Caleco Pharma Corp.

(OTCBB: CAEH.OB)(FRANKFURT:T3R)(WKN:A0N9Y0) ("Caleco Pharma") ( www.calecopharmacorp.com) is pleased to announce that it has entered into a designated sponsorship agreement (the...

Yahoo! Canada:  Feb 9 2010 6:34PM
Matching: agreement
Find similar documents
HTML
100%
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater Advisory Group LLC as Investor Relations Consultant
(Marketwire via COMTEX) ----Caleco Pharma Corp.

(OTCBB:CAEH)(FRANKFURT:T3R)(WKN:A0N9Y0) ("Caleco Pharma") (www.calecopharmacorp.com) is pleased to announce that it has entered into a designated sponsorship agreement (the "Sponsorship Agreement")...

FOXBusiness.com:  Feb 9 2010 4:23PM
Matching: agreement
Find similar documents
HTML
100%
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater
BELLINGHAM, WASHINGTON--(Marketwire - Feb.

9, 2010) - Caleco Pharma Corp.

(OTCBB:CAEH - News; FRANKFURT:T3R - News; WKN:A0N9Y0) ('Caleco Pharma') (www.calecopharmacorp.com) is pleased to announce that it has entered into a designated sponsorship ...

Yahoo! Canada:  Feb 9 2010 3:30PM
Matching: agreement
Find similar documents
HTML
100%
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater Advisory Group LLC ..
Caleco Pharma Corp.

Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater Advisory Group LLC as Investor Relations Consultant Refer to a friend Marketwire 2010 BELLINGHAM, WASHINGTON -- (Marketwire) -- 02/09/10 -- Caleco...

PR inside:  Feb 9 2010 2:55PM
Matching: agreement
Find similar documents
HTML
100%
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater Advisory Group LLC as Investor Relations Consultant
(Marketwire via COMTEX News Network) -- Caleco Pharma Corp.

(OTCBB:CAEH)(FRANKFURT:T3R)(WKN:A0N9Y0) ("Caleco Pharma") (www.calecopharmacorp.com) is pleased to announce that it has entered into a designated sponsorship agreement (the "Sponsorship ...

Quote.com Canada:  Feb 9 2010 2:44PM
Matching: agreement
Find similar documents
HTML
100%
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater
roup LLC as Investor Relations Consultant Caleco Pharma Corp.

(OTCBB: CAEH)(FRANKFURT: T3R)(WKN: A0N9Y0) ('Caleco Pharma') (www.calecopharmacorp.com) is pleased to announce that it has entered into a designated sponsorship agreement (the 'Sponsorship ...

NewsBlaze:  Feb 9 2010 2:09PM
Matching: agreement
Find similar documents
HTML
100%
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater
Email a Friend Latest News Releases Permalink BELLINGHAM, WASHINGTON--(Marketwire - Feb.

9, 2010) - Caleco Pharma Corp.

(OTCBB:CAEH)(FRANKFURT:T3R)(WKN:A0N9Y0) ('Caleco Pharma') (www.calecopharmacorp.com) is pleased to announce that it has entered into a...

Market Wire:  Feb 9 2010 2:06PM
Matching: agreement
Find similar documents
HTML
100%
PuraMed BioScience Secures up to $7.5 Million Funding Commitment From Southridge Partners II, Ltd.
(GlobeNewswire via COMTEX) ----PuraMed BioScience (OTCBB:PMBS), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches...
FOXBusiness.com:  Feb 9 2010 4:24PM
Matching: agreement
Find similar documents
HTML
100%
PuraMed BioScience Secures up to $7.5 Million Funding Commitment From Southridge Partners II, Ltd
SCHOFIELD, Wis., Feb.

9, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS - News), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and...

GlobeNewswire via Yahoo!:  Feb 9 2010 2:18PM
Matching: agreement
Find similar documents
HTML
100%
PuraMed BioScience Secures up to $7.5 Million Funding Commitment
SCHOFIELD, Wis., Feb.

9, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and...

GlobeNewswire via MSN Money:  Feb 9 2010 2:15PM
Matching: agreement
Find similar documents
HTML
100%
NUCRYST Announces Completion of Amalgamation
Latest Health News PRINCETON, NJ, Feb.

8 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp.

('Nucryst') (TSX:NCS / NASDAQ:NCST) today is pleased to announce the completion of the previously announced amalgamation (the 'Amalgamation') of Nucryst with...

Montana's News Station:  Feb 9 2010 11:14PM
Matching: agreement
Find similar documents
HTML
100%
NUCRYST Announces Completion of Amalgamation
PRINCETON, NJ, Feb.

8 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp.

('Nucryst') (TSX:NCS / NASDAQ:NCST) today is pleased to announce the completion of the previously announced amalgamation (the 'Amalgamation') of Nucryst with 1499642 Alberta Ltd.

KSLA:  Feb 9 2010 10:20AM
Matching: agreement
Find similar documents
HTML
100%
Chi-Fu Trading to market and sell Delcath PHP Systems in Taiwan
Delcath Systems, Inc.

( DCTH), a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today the signing of its first research, distribution, sales and marketing agreement for its...

News-Medical.Net:  Feb 9 2010 1:20PM
Matching: agreement
Find similar documents
HTML
100%
More Choice for Canadians Travelling to Morocco
The Honourable Rob Merrifield, Minister of State (Transport), today met with Karim Ghellab, Morocco's Minister of Equipment and Transport, to discuss the recently expanded air transport agreement between the two countries.

The ministers had a bilateral...

Genetic Engineering News:  Feb 9 2010 8:23PM
Matching: agreement
Find similar documents
HTML
100%
Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement
ROCKVILLE, Md., Feb.

9, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI - News) (the 'Company') announced today that it has commenced mailing its definitive proxy statement to stockholders for approval of the exclusive option and license ...

Yahoo! Canada:  Feb 9 2010 5:27PM
Matching: agreement
Find similar documents
HTML
100%
Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement
(GlobeNewswire via COMTEX) ----Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") announced today that it has commenced mailing its definitive proxy statement to stockholders for approval of the exclusive option and license agreement ("the NicVAX ...
FOXBusiness.com:  Feb 9 2010 4:37PM
Matching: agreement
Find similar documents
HTML
100%
Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement
ROCKVILLE, Md., Feb.

9, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (the 'Company') announced today that it has commenced mailing its definitive proxy statement to stockholders for approval of the exclusive option and license agreement ('the NicVAX...

Interest!ALERT:  Feb 9 2010 3:16PM
Matching: agreement
Find similar documents
HTML
100%
Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy
ROCKVILLE, Md., Feb.

9, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the 'Company') announced today that it has commenced mailing its definitive proxy statement to stockholders for approval of the exclusive option and license agreement...

GlobeNewswire via MSN Money:  Feb 9 2010 2:27PM
Matching: agreement
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.